For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231012:nRSL9396Pa&default-theme=true
RNS Number : 9396P Integrated Diagnostics Holdings PLC 12 October 2023
INTEGRATED DIAGNOSTICS HOLDINGS PLC
(the "Company")
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
The following notification is made in accordance with Articles 19.1 and 19.3
of the Market Abuse Regulation.
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Hena Holdings Ltd
2. Reason for the notification
a) Position / status PCA of Dr Hend El Sherbini, Chief Executive Officer
b) Initial notification / amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Integrated Diagnostics Holding plc
b) LEI 2138007JN9NUWKKTS790
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument IDH Ordinary Shares of $0.25 each
Identification Code
JE00BLKGSR75
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) per share Volume(s)
USD 0.4482 43,221
d) Aggregated information 43,221
Aggregated volume USD 0.4482 per share
Price
e) Date of the transaction 11 October 2023
f) Place of the transaction London Stock Exchange
d)
Aggregated information
Aggregated volume
Price
43,221
USD 0.4482 per share
e)
Date of the transaction
11 October 2023
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGCBDGBXBDGXD